Advancis Files NDA For Pulsatile Amoxicillin
This article was originally published in The Pink Sheet Daily
Executive Summary
The company does not rule out the possibility of copromoting the first once-daily formulation of the antibiotic as a way of expanding its sales force if Amoxicillin Pulsys is approved.